🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to examine efficacy and safety of epcoritamab w...
Status
Terminated
Location
UW Cancer Center at ProHealth Care
Start Date
2023-03-06
Trial ID
NCT05660967
Treatments Being Tested
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells ...
Status
Active Not Recruiting
Location
Infirmary Health - Infirmary Cancer Care at Mobile Infirmary /ID# 264630
Start Date
2022-08-17
Trial ID
NCT05451810
Treatments Being Tested
The drug that will be investigated in the study is an antibody, GEN3009. Si...
Status
Terminated
Location
Colorado Blood Cancer Institute
Start Date
2020-03-13
Trial ID
NCT04358458
Treatments Being Tested
The purpose of this study is to measure the efficacy of the study drug, epc...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2025-06-05
Trial ID
NCT06811272
phase II, response-adaptive, open-label, multicenter study aiming to includ...
Status
Recruiting
Location
Hospital Universitario Miguel Servet
Start Date
2025-08-04
Trial ID
NCT07126236
Treatments Being Tested
The trial is an open-label, multi-center safety and preliminary efficacy tr...
Status
Active Not Recruiting
Location
Tohoku University Hoaspital
Start Date
2020-08-20
Trial ID
NCT04542824
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells ...
Status
Active Not Recruiting
Location
The Fifth Medical Center of PLA General Hospital /ID# 230520
Start Date
2022-03-10
Trial ID
NCT05201248
Treatments Being Tested